RaQualia Pharma Inc.
4579.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥3,543,230 | ¥3,422,513 | ¥2,764,423 | ¥3,141,929 |
| Short-Term Investments | ¥0 | ¥89,139 | ¥0 | ¥199,999 |
| Receivables | ¥549,260 | ¥714,945 | ¥1,155,998 | ¥689,162 |
| Inventory | ¥184,833 | ¥171,742 | ¥170,858 | ¥167,722 |
| Other Curr. Assets | ¥96,762 | ¥55,383 | ¥173,792 | ¥146,561 |
| Total Curr. Assets | ¥4,639,597 | ¥4,908,939 | ¥4,482,951 | ¥4,538,963 |
| Property Plant & Equip (Net) | ¥480,221 | ¥526,437 | ¥548,921 | ¥529,082 |
| Goodwill | ¥3,697,860 | ¥3,766,339 | ¥3,834,818 | ¥3,865,297 |
| Intangibles | ¥35,632 | ¥34,569 | ¥34,156 | ¥36,978 |
| Long-Term Investments | ¥536,806 | ¥569,978 | ¥474,084 | ¥547,053 |
| Tax Assets | ¥73,243 | ¥75,372 | ¥78,701 | ¥78,460 |
| Other NC Assets | ¥55,154 | ¥54,506 | ¥57,070 | ¥59,649 |
| Total NC Assets | ¥4,878,916 | ¥5,027,201 | ¥5,027,750 | ¥5,116,519 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥9,518,513 | ¥9,936,140 | ¥9,510,701 | ¥9,655,482 |
| Liabilities | – | – | – | – |
| Payables | ¥58,256 | ¥54,576 | ¥60,288 | ¥59,317 |
| Short-Term Debt | ¥589,088 | ¥589,512 | ¥590,252 | ¥582,277 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥72,654 | ¥155,702 | ¥185,829 |
| Other Curr. Liab. | ¥311,036 | ¥211,465 | ¥307,321 | ¥221,279 |
| Total Curr. Liab. | ¥995,303 | ¥1,023,127 | ¥1,225,599 | ¥1,187,495 |
| LT Debt | ¥2,266,965 | ¥2,395,120 | ¥2,523,275 | ¥2,651,430 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥20,486 | ¥18,735 | ¥30,776 | ¥27,421 |
| Total NC Liab. | ¥2,480,834 | ¥2,626,082 | ¥2,785,008 | ¥2,897,478 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥289,119 | ¥308,589 | ¥288,284 |
| Total Liabilities | ¥3,476,137 | ¥3,649,209 | ¥4,010,607 | ¥4,084,973 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥3,240,586 | ¥3,240,586 | ¥2,720,540 | ¥2,720,540 |
| Retained Earnings | -¥614,657 | -¥400,420 | -¥50,888 | -¥45,673 |
| AOCI | -¥13,821 | ¥16,497 | -¥79,780 | -¥14,579 |
| Other Equity | -¥1 | -¥1 | -¥1 | ¥0 |
| Total Equity | ¥6,042,374 | ¥6,286,929 | ¥5,500,092 | ¥5,570,509 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥9,518,511 | ¥9,936,138 | ¥9,510,699 | ¥9,655,482 |
| Net Debt | -¥687,177 | -¥437,881 | ¥349,104 | ¥91,778 |